Photo of Yuan-Chin Tsai

View Scopus Profile

Yuan-Chin Tsai

Associate Professor

 https://orcid.org/0000-0003-3264-3513
  • 1064 Citations
  • 14 h-Index
20042019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2008 Ph.D Rutgers UniversityPharmacology
  • 1998 M.S., Institute of Biochemistry and Molecular Biology
  • 1996 B.S., Department of Agriculture Chemistry, National Taiwan University

Experience

  • 2018- Assiociate Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
  • 2018- Assiociate Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
  • 2013-2018 Assistant Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
  • 2009-2013 Postdoc, Princeton University

Research Interests

  • DNA damage
  • tumor biology
  • vaccine design

URL

Fingerprint Dive into the research topics where Yuan-Chin Tsai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

研究去勢療法之後的前列腺癌病變及發展阻斷發炎的癌症免疫療法

Tsai, Y.

8/1/18 → 7/1/19

Project: A - Government Institution › b - Ministry of Science and Technology

探討microRNA96在轉化生長因子β導致的癌症演進過程的角色(3/3)

Tsai, Y.

8/1/17 → 7/31/18

Project: A - Government Institution › b - Ministry of Science and Technology

探討microRNA96在轉化生長因子β導致的癌症演進過程的角色(2/3)

Tsai, Y.

8/1/16 → 7/31/17

Project: A - Government Institution › b - Ministry of Science and Technology

Roles of microRNA96 in TGF-beta-Mediated Tumor Progression

Tsai, Y.

8/1/15 → 7/31/16

Project: A - Government Institution › b - Ministry of Science and Technology

TMU102-AE1-B30

Tsai, Y.

4/1/14 → 12/31/16

Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty

Research Output

  • 1064 Citations
  • 14 h-Index
  • 29 Article
  • 1 Editorial

Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2

Tsai, Y. C., Chen, W. Y., Abou-Kheir, W., Zeng, T., Yin, J. J., Bahmad, H., Lee, Y. C. & Liu, Y. N., May 1 2018, In : Biochimica et Biophysica Acta - Molecular Basis of Disease. 1864, 5, p. 1717-1727 11 p.

Research output: Contribution to journal › Article

    • 6 Citations (Scopus)

    A synergistic anti-cancer effect of troglitazone and lovastatin in a human anaplastic thyroid cancer cell line and in a mouse xenograft model

    Zhong, W. B., Tsai, Y. C., Chin, L. H., Tseng, J. H., Tang, L. W., Horng, S., Fan, Y. C. & Hsu, S. P., Jul 1 2018, In : International Journal of Molecular Sciences. 19, 7, 1834.

    Research output: Contribution to journal › Article

    • 6 Citations (Scopus)

    Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer

    Tsai, Y. C., Zeng, T., Abou-Kheir, W., Yeh, H. L., Yin, J. J., Lee, Y. C., Chen, W. Y. & Liu, Y. N., Feb 19 2018, In : Molecular Cancer. 17, 1, 42.

    Research output: Contribution to journal › Article

    • 1 Citation (Scopus)

    Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6

    Tsai, Y. C., Chen, W. Y., Siu, M. K., Tsai, H. Y., Yin, J. J., Huang, J. & Liu, Y. N., Jan 1 2017, In : Cancer Letters. 384, p. 1-8 8 p.

    Research output: Contribution to journal › Article

    • 10 Citations (Scopus)

    Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis

    Chen, W-Y., Tsai, Y-C., Siu, M. K., Yeh, H-L., Chen, C-L., Yin, J. J., Huang, J. & Liu, Y-N., Jul 10 2017, In : Oncogene. p. 6213-6224

    Research output: Contribution to journal › Article

    • 10 Citations (Scopus)